EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Switch Symbol:
Price to Sales: Discounted Valuation
Trending lower, below historical average, modest growth trend.
Left:
||||
Price-to-sales ratio
Latest
9.69
↓ 36% below average
Average (9y)
15.17
Historical baseline
Range
High:55.24
Low:2.45
CAGR
+9.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 9.69 | -49.1% |
| 2023 | 19.04 | +503.5% |
| 2022 | 3.15 | -66.9% |
| 2021 | 9.53 | +288.5% |
| 2020 | 2.45 | -69.1% |
| 2019 | 7.94 | -75.6% |
| 2018 | 32.47 | +305.1% |
| 2017 | 8.02 | -85.5% |
| 2016 | 55.24 | +1225.0% |
| 2015 | 4.17 | - |